{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:28:28Z","timestamp":1788571708720,"version":"build-2803163510"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":67,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Forschung, Technologie und Raumfahrt","doi-asserted-by":"publisher","award":["FKZ 01GM2204A"],"award-info":[{"award-number":["FKZ 01GM2204A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bpg.2025.102064","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T02:58:05Z","timestamp":1762570685000},"page":"102064","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Circulating and faecal microRNAs as non-invasive biomarkers for IBD: current evidence and next steps"],"prefix":"10.1016","volume":"78","author":[{"given":"Vytautas","family":"Kiudelis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juozas","family":"Kupcinskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9514-4562","authenticated-orcid":false,"given":"Alexander","family":"Link","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10114","key":"10.1016\/j.bpg.2025.102064_bib1","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2025.102064_bib2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41575-020-00360-x","article-title":"The four epidemiological stages in the global evolution of inflammatory bowel disease","volume":"18","author":"Kaplan","year":"2021","journal-title":"Nature Reviews Gastroenterology and Hepatology Nature Research"},{"key":"10.1016\/j.bpg.2025.102064_bib3","doi-asserted-by":"crossref","DOI":"10.14309\/ajg.0000000000002687","article-title":"Forecasting the incidence and prevalence of inflammatory bowel disease: a Canadian nationwide analysis","author":"Coward","year":"2024","journal-title":"American Journal of Gastroenterology [Internet]"},{"issue":"7422","key":"10.1016\/j.bpg.2025.102064_bib4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nature11582","article-title":"Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease","volume":"491","author":"Jostins","year":"2012","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.bpg.2025.102064_bib5","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/ng.3359","article-title":"Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations","volume":"47","author":"Liu","year":"2015","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.bpg.2025.102064_bib6","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1053\/j.gastro.2008.07.068","article-title":"MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory Peptide-2\u03b1","volume":"135","author":"Wu","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2025.102064_bib7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/B978-0-12-800096-0.00006-8","article-title":"MicroRNA in gastrointestinal cancer. A step closer to reality","volume":"62","author":"Link","year":"2013","journal-title":"Adv Clin Chem [Internet]"},{"issue":"3","key":"10.1016\/j.bpg.2025.102064_bib8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000336919","article-title":"Macro-role of microRNA in gastric cancer","volume":"30","author":"Link","year":"2012","journal-title":"Dig Dis [Internet]"},{"issue":"30","key":"10.1016\/j.bpg.2025.102064_bib9","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.3748\/wjg.v24.i30.3313","article-title":"MicroRNAs as non-invasive diagnostic biomarkers for gastric cancer: current insights and future perspectives","volume":"24","author":"Link","year":"2018","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.bpg.2025.102064_bib10","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1080\/00365520500217118","article-title":"Clinically active Crohn's disease in the presence of a low C-reactive protein","volume":"41","author":"Florin","year":"2006","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"10.1016\/j.bpg.2025.102064_bib11","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s10620-013-2907-3","article-title":"Correlations of C-reactive protein levels and erythrocyte sedimentation rates with endoscopic activity indices in patients with ulcerative colitis","volume":"59","author":"Yoon","year":"2014","journal-title":"Dig Dis Sci"},{"issue":"10","key":"10.1016\/j.bpg.2025.102064_bib12","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1111\/j.1572-0241.2006.00840.x","article-title":"Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease","volume":"101","author":"Reese","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.bpg.2025.102064_bib13","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/ajg.2015.120","article-title":"C-reactive protein, fecal calprotectin, and stool lactoferrin for detection of endoscopic activity in symptomatic inflammatory bowel disease patients: a systematic review and meta-analysis","volume":"110","author":"Mosli","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.bpg.2025.102064_bib14","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","article-title":"ECCO-ESGAR guideline for diagnostic assessment in IBD part 1: initial diagnosis, monitoring of known IBD, detection of complications","volume":"13","author":"Maaser","year":"2018","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.bpg.2025.102064_bib15","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.coph.2020.10.001","article-title":"Preclinical disease and preventive strategies in IBD","volume":"55","author":"Morao","year":"2020","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.bpg.2025.102064_bib16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function review","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"issue":"7385","key":"10.1016\/j.bpg.2025.102064_bib17","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nature10888","article-title":"The microcosmos of cancer","volume":"482","author":"Lujambio","year":"2012","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bpg.2025.102064_bib18","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nri.2016.40","article-title":"MicroRNAs as regulatory elements in immune system logic","volume":"16","author":"Mehta","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"10.1016\/j.bpg.2025.102064_bib19","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1053\/j.gastro.2010.07.040","article-title":"MicroRNAs control intestinal epithelial differentiation, architecture, and barrier function","volume":"139","author":"McKenna","year":"2010","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.bpg.2025.102064_bib20","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1074\/jbc.M109.057141","article-title":"MicroRNA-7 modulates CD98 expression during intestinal epithelial cell differentiation","volume":"285","author":"Nguyen","year":"2010","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.bpg.2025.102064_bib21","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1136\/gutjnl-2012-304213","article-title":"MIR-141 regulates colonic leukocytic trafficking by targeting CXCL12\u03b2 during murine colitis and human crohn's disease","volume":"63","author":"Huang","year":"2014","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.bpg.2025.102064_bib22","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1136\/gutjnl-2015-309389","article-title":"MIR-301a promotes intestinal mucosal inflammation through induction of IL-17A and TNF-\u03b1 in IBD","volume":"65","author":"He","year":"2016","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.bpg.2025.102064_bib23","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ibd.21742","article-title":"MiR-143 and miR-145 are downregulated in ulcerative colitis: putative regulators of inflammation and protooncogenes","volume":"18","author":"Pekow","year":"2012","journal-title":"Inflamm Bowel Dis"},{"issue":"9","key":"10.1016\/j.bpg.2025.102064_bib24","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1097\/MIB.0000000000000453","article-title":"MiRNA-26b overexpression in ulcerative colitis-associated carcinogenesis","volume":"21","author":"Benderska","year":"2015","journal-title":"Inflamm Bowel Dis"},{"issue":"30","key":"10.1016\/j.bpg.2025.102064_bib25","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection","volume":"105","author":"Mitchell","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10.1016\/j.bpg.2025.102064_bib26","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1373\/clinchem.2010.147405","article-title":"The microRNA spectrum in 12 body fluids","volume":"56","author":"Weber","year":"2010","journal-title":"Clin Chem"},{"issue":"00","key":"10.1016\/j.bpg.2025.102064_bib27","first-page":"1","article-title":"Circulating and fecal microRNAs as biomarkers for inflammatory bowel diseases","volume":"00","author":"Sch\u00f6nauen","year":"2018","journal-title":"Inflamm Bowel Dis [Internet]"},{"issue":"5","key":"10.1016\/j.bpg.2025.102064_bib28","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/cncy.21966","article-title":"Expression of microRNAs in the ascites of patients with peritoneal carcinomatosis and peritonitis","volume":"126","author":"Schindler","year":"2018","journal-title":"Cancer Cytopathol"},{"issue":"1","key":"10.1016\/j.bpg.2025.102064_bib29","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ibd.21450","article-title":"Peripheral blood microRNAs distinguish active ulcerative colitis and Crohn's disease","volume":"17","author":"Wu","year":"2011","journal-title":"Inflamm Bowel Dis"},{"issue":"9","key":"10.1016\/j.bpg.2025.102064_bib30","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1097\/MIB.0000000000000883","article-title":"Identification of circulating MicroRNA signatures in crohn's disease using the nanostring nCounter technology","volume":"22","author":"Oikonomopoulos","year":"2016","journal-title":"Inflamm Bowel Dis"},{"issue":"11","key":"10.1016\/j.bpg.2025.102064_bib31","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1097\/MIB.0000000000000547","article-title":"Assessment of circulating MicroRNAs for the diagnosis and disease activity evaluation in patients with ulcerative colitis by using the nanostring technology","volume":"21","author":"Polytarchou","year":"2015","journal-title":"Inflamm Bowel Dis"},{"issue":"9","key":"10.1016\/j.bpg.2025.102064_bib32","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1097\/MEG.0000000000000430","article-title":"Circulating microRNAs as biomarkers of adult Crohn's disease","volume":"27","author":"Jensen","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.bpg.2025.102064_bib33","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/MIB.0000000000000285","article-title":"Overexpression of miR-595 and miR-1246 in the sera of patients with active forms of inflammatory bowel disease","volume":"21","author":"Krissansen","year":"2015","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.bpg.2025.102064_bib34","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/MPG.0b013e31822200cc","article-title":"Circulating microRNA is a biomarker of pediatric crohn disease","volume":"53","author":"Zahm","year":"2011","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"10.1016\/j.bpg.2025.102064_bib35","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/cei.12104","article-title":"Identification of serum and tissue micro-RNA expression profiles in different stages of inflammatory bowel disease","volume":"173","author":"Iborra","year":"2013","journal-title":"Clin Exp Immunol"},{"issue":"8","key":"10.1016\/j.bpg.2025.102064_bib36","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1097\/MIB.0000000000000443","article-title":"Low serum levels of microRNA-19 are associated with a stricturing Crohn's disease phenotype","volume":"21","author":"Lewis","year":"2015","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"10.1016\/j.bpg.2025.102064_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031241","article-title":"Genome-wide maps of circulating miRNA biomarkers for ulcerative colitis","volume":"7","author":"Duttagupta","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.bpg.2025.102064_bib38","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/ecco-jcc\/jjy010","article-title":"Differential expression of microRNAs in peripheral blood mononuclear cells identifies autophagy and TGF-beta-related signatures aberrantly expressed in inflammatory bowel disease","volume":"12","author":"Mohammadi","year":"2018","journal-title":"J Crohns Colitis"},{"issue":"1","key":"10.1016\/j.bpg.2025.102064_bib39","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/ibd\/izx009","article-title":"Plasma microRNA profile differentiates crohn's colitis from ulcerative colitis","volume":"24","author":"Netz","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2025.102064_bib40","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjaa134","article-title":"Whole blood profiling of T-cell derived miRNA allows the development of prognostic models in inflammatory bowel disease","author":"Kalla","year":"2020","journal-title":"J Crohns Colitis"},{"issue":"10","key":"10.1016\/j.bpg.2025.102064_bib41","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/ibd\/izaa209","article-title":"Serum miRNAs are pharmacodynamic biomarkers associated with therapeutic response in pediatric inflammatory bowel disease","volume":"26","author":"Batra","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2025.102064_bib42","first-page":"1","article-title":"Detailed transcriptional landscape of peripheral blood points to increased neutrophil activation in treatment-na\u00efve inflammatory bowel disease","author":"Juzenas","year":"2022","journal-title":"J Crohns Colitis"},{"issue":"4","key":"10.1016\/j.bpg.2025.102064_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biology11040508","article-title":"Plasma miRNA profile of crohn's disease and rheumatoid arthritis patients","volume":"11","author":"Saccon","year":"2022","journal-title":"Biology"},{"issue":"10","key":"10.1016\/j.bpg.2025.102064_bib44","article-title":"Peripheral blood mononuclear cell microRNAs are novel biomarkers for diagnosing and monitoring Crohn's disease","volume":"36","author":"Chen","year":"2022","journal-title":"FASEB (Fed Am Soc Exp Biol) J"},{"key":"10.1016\/j.bpg.2025.102064_bib45","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1016\/j.bbrc.2018.06.174","article-title":"Faecal microRNA as a biomarker of the activity and prognosis of inflammatory bowel diseases","volume":"503","author":"Ji","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.bpg.2025.102064_bib46","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/ecco-jcc\/jjz120","article-title":"Faecal Micro-RNAs in inflammatory bowel diseases","volume":"14","author":"Verdier","year":"2020","journal-title":"J Crohns Colitis"},{"issue":"1","key":"10.1016\/j.bpg.2025.102064_bib47","first-page":"1","article-title":"Fecal MicroRNAs show promise as noninvasive crohn's disease biomarkers","volume":"2","author":"Wohnhaas","year":"2020","journal-title":"Crohns Colitis 360"},{"issue":"1","key":"10.1016\/j.bpg.2025.102064_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12876-020-01444-3","article-title":"In search for interplay between stool microRNAs, microbiota and short chain fatty acids in Crohn's disease - a preliminary study","volume":"20","author":"Ambrozkiewicz","year":"2020","journal-title":"BMC Gastroenterol"},{"issue":"5","key":"10.1016\/j.bpg.2025.102064_bib49","first-page":"1","article-title":"Circulating MicroRNA223 is a new biomarker for inflammatory bowel disease","volume":"95","author":"Wang","year":"2016","journal-title":"Medicine (United States)"},{"issue":"1","key":"10.1016\/j.bpg.2025.102064_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12865-015-0069-0","article-title":"MicroRNA signatures differentiate Crohn's disease from ulcerative colitis","volume":"16","author":"Schaefer","year":"2015","journal-title":"BMC Immunol"},{"issue":"1","key":"10.1016\/j.bpg.2025.102064_bib51","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2174\/1874091X01812010078","article-title":"Micro-RNAs -106a and -362-3p in peripheral blood of inflammatory bowel disease patients","volume":"12","author":"Omidbakhsh","year":"2018","journal-title":"Open Biochem J [Internet]"},{"issue":"9","key":"10.1016\/j.bpg.2025.102064_bib52","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.crohns.2012.02.006","article-title":"Circulating MicroRNA in inflammatory bowel disease","volume":"6","author":"Paraskevi","year":"2012","journal-title":"J Crohns Colitis [Internet]"},{"key":"10.1016\/j.bpg.2025.102064_bib53","first-page":"1486","article-title":"Peripheral blood miR-372 as a biomarker for ulcerative colitis via direct targeting of NLRP12","author":"Shen","year":"2019","journal-title":"Exp Ther Med"},{"issue":"6","key":"10.1016\/j.bpg.2025.102064_bib54","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/apt.15159","article-title":"Circulating microRNA146b-5p is superior to C-reactive protein as a novel biomarker for monitoring inflammatory bowel disease","volume":"49","author":"Chen","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.bpg.2025.102064_bib55","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/08820139.2015.1103749","article-title":"Altered microRNA expression and immunosuppressive cytokine production by regulatory t cells of ulcerative colitis patients","volume":"45","author":"Mohammadnia-Afrouzi","year":"2016","journal-title":"Immunol Invest [Internet]"},{"issue":"April","key":"10.1016\/j.bpg.2025.102064_bib56","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jaut.2019.04.014","article-title":"MicroRNA-125a suppresses intestinal mucosal inflammation through targeting ETS-1 in patients with inflammatory bowel diseases","volume":"101","author":"Ge","year":"2019","journal-title":"J Autoimmun [Internet]"},{"issue":"3","key":"10.1016\/j.bpg.2025.102064_bib57","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000134","article-title":"MicroRNA-320a monitors intestinal disease activity in patients with inflammatory bowel disease","volume":"11","author":"Cordes","year":"2020","journal-title":"Clin Transl Gastroenterol"},{"issue":"10 October","key":"10.1016\/j.bpg.2025.102064_bib58","article-title":"Expression profile of serum LncRNA THRIL and MiR-125b in inflammatory bowel disease","volume":"17","author":"Elamir","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.bpg.2025.102064_bib59","first-page":"252","article-title":"Differential expression of serum miR-486 and miR-25 in ulcerative colitis and Crohn's disease: correlations with disease activity, extent, and location","author":"Abdelazim","year":"2023","journal-title":"Pathol Res Pract"},{"issue":"2","key":"10.1016\/j.bpg.2025.102064_bib60","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/kjm2.12784","article-title":"Tissue and serum miR-149-3p\/5p in hospitalized patients with inflammatory bowel disease: correlation with disease severity and inflammatory markers","volume":"40","author":"Luo","year":"2024","journal-title":"Kaohsiung J Med Sci"},{"issue":"9","key":"10.1016\/j.bpg.2025.102064_bib61","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/ibd\/izad210","article-title":"Circulating miR-199a and long noncoding-RNA ANRIL as promising diagnostic biomarkers for inflammatory bowel disease","volume":"30","author":"Erfan","year":"2024","journal-title":"Inflamm Bowel Dis"},{"issue":"44","key":"10.1016\/j.bpg.2025.102064_bib62","doi-asserted-by":"crossref","first-page":"7888","DOI":"10.3748\/wjg.v23.i44.7888","article-title":"Circulating miR-125a but not miR-125b is decreased in active disease status and negatively correlates with disease severity as well as inflammatory cytokines in patients with Crohn's disease","volume":"23","author":"Sun","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.bpg.2025.102064_bib63","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1042\/CS20140048","article-title":"In Crohn's disease fibrosis-reduced expression of the miR-29 family enhances collagen expression in intestinal fibroblasts","volume":"127","author":"Nijhuis","year":"2014","journal-title":"Clin Sci (Lond)"},{"issue":"5","key":"10.1016\/j.bpg.2025.102064_bib64","doi-asserted-by":"crossref","first-page":"258","DOI":"10.21037\/atm-22-475","article-title":"Circulating exosomal miR-21 mediates HUVEC proliferation and migration through PTEN\/PI3K\/AKT in Crohn's disease","volume":"10","author":"Xie","year":"2022","journal-title":"Ann Transl Med"},{"issue":"June","key":"10.1016\/j.bpg.2025.102064_bib65","first-page":"1","article-title":"Serum exosomal microRNA-144-3p: a promising biomarker for monitoring Crohn's disease","volume":"10","author":"Chen","year":"2022","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"1","key":"10.1016\/j.bpg.2025.102064_bib66","doi-asserted-by":"crossref","first-page":"30","DOI":"10.15403\/jgld-4656","article-title":"Tissue and circulating MicroRNA-31, MicroRNA-200b, and MicroRNA-200c reflects disease activity in crohn\u2018s disease patients: results from the BIOMIR study","volume":"32","author":"Tocia","year":"2023","journal-title":"Journal of Gastrointestinal and Liver Diseases"},{"issue":"12","key":"10.1016\/j.bpg.2025.102064_bib67","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.1131","article-title":"Fecal miR-223 is a noninvasive biomarker for estimating Crohn's disease activity","volume":"11","author":"Zhang","year":"2023","journal-title":"Immun Inflamm Dis"},{"issue":"3","key":"10.1016\/j.bpg.2025.102064_bib68","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/ibd\/izad181","article-title":"Expression of circulating let-7e and miR-126 may predict clinical remission in patients with crohn's disease treated with Anti-TNF-\u03b1 biologics","volume":"30","author":"Guglielmi","year":"2024","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"10.1016\/j.bpg.2025.102064_bib69","doi-asserted-by":"crossref","DOI":"10.1177\/03000605251328245","article-title":"Prediction of postoperative recurrence of perianal fistulizing Crohn's disease by fecal calprotectin combined with serum miRNA6086","volume":"53","author":"Jin","year":"2025","journal-title":"J Int Med Res"},{"issue":"7","key":"10.1016\/j.bpg.2025.102064_bib70","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1158\/1055-9965.EPI-10-0027","article-title":"Fecal microRNAs as novel biomarkers for Colon cancer screening","volume":"19","author":"Link","year":"2010","journal-title":"Cancer Epidemiology Biomarkers and Prevention [Internet]"},{"key":"10.1016\/j.bpg.2025.102064_bib71","article-title":"Feasibility of fecal MicroRNAs as novel biomarkers for pancreatic cancer","volume":"vol. 7","author":"Link","year":"2012"},{"issue":"5","key":"10.1016\/j.bpg.2025.102064_bib72","first-page":"281","article-title":"Diagnostic microRNA markers for screening sporadic human colon cancer and active ulcerative colitis in stool and tissue","volume":"6","author":"Ahmed","year":"2009","journal-title":"Cancer Genomics Proteomics"},{"issue":"4","key":"10.1016\/j.bpg.2025.102064_bib73","article-title":"Comparison of fecal MicroRNA isolation using various total RNA isolation kits","volume":"15","author":"Lederer","year":"2024","journal-title":"Genes (Basel) [Internet]"},{"issue":"2","key":"10.1016\/j.bpg.2025.102064_bib74","article-title":"Food-derived Xeno-microRNAs: influence of diet and detectability in gastrointestinal tract-proof-of-principle study","volume":"63","author":"Link","year":"2019","journal-title":"Mol Nutr Food Res [Internet]"},{"issue":"16","key":"10.1016\/j.bpg.2025.102064_bib75","article-title":"The translational impact of plant-derived Xeno-miRNA miR-168 in gastrointestinal cancers and preneoplastic conditions","volume":"13","author":"Link","year":"2023","journal-title":"Diagnostics (Basel) [Internet]"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691825000915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691825000915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T21:59:50Z","timestamp":1773871190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691825000915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":75,"alternative-id":["S1521691825000915"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2025.102064","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating and faecal microRNAs as non-invasive biomarkers for IBD: current evidence and next steps","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpg.2025.102064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102064"}}